TrialPloS one2010

Safety, immunogenicity and duration of protection of the RTS,S/AS02(D) malaria vaccine: one year follow-up of a randomized controlled phase I/IIb trial.

Pedro Aide et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.